Literature DB >> 20421415

Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrest.

Atsushi Shibata1, Olivia Barton, Angela T Noon, Kirsten Dahm, Dorothee Deckbar, Aaron A Goodarzi, Markus Löbrich, Penny A Jeggo.   

Abstract

ATM-dependent initiation of the radiation-induced G(2)/M checkpoint arrest is well established. Recent results have shown that the majority of DNA double-strand breaks (DSBs) in G(2) phase are repaired by DNA nonhomologous end joining (NHEJ), while approximately 15% of DSBs are slowly repaired by homologous recombination. Here, we evaluate how the G(2)/M checkpoint is maintained in irradiated G(2) cells, in light of our current understanding of G(2) phase DSB repair. We show that ATM-dependent resection at a subset of DSBs leads to ATR-dependent Chk1 activation. ATR-Seckel syndrome cells, which fail to efficiently activate Chk1, and small interfering RNA (siRNA) Chk1-treated cells show premature mitotic entry. Thus, Chk1 significantly contributes to maintaining checkpoint arrest. Second, sustained ATM signaling to Chk2 contributes, particularly when NHEJ is impaired by XLF deficiency. We also show that cells lacking the mediator proteins 53BP1 and MDC1 initially arrest following radiation doses greater than 3 Gy but are subsequently released prematurely. Thus, 53BP1(-/-) and MDC1(-/-) cells manifest a checkpoint defect at high doses. This failure to maintain arrest is due to diminished Chk1 activation and a decreased ability to sustain ATM-Chk2 signaling. The combined repair and checkpoint defects conferred by 53BP1 and MDC1 deficiency act synergistically to enhance chromosome breakage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20421415      PMCID: PMC2897583          DOI: 10.1128/MCB.01644-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Regulation of Saccharomyces Rad53 checkpoint kinase during adaptation from DNA damage-induced G2/M arrest.

Authors:  A Pellicioli; S E Lee; C Lucca; M Foiani; J E Haber
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

2.  53BP1, a mediator of the DNA damage checkpoint.

Authors:  Bin Wang; Shuhei Matsuoka; Phillip B Carpenter; Stephen J Elledge
Journal:  Science       Date:  2002-10-03       Impact factor: 47.728

3.  Pathways of DNA double-strand break repair during the mammalian cell cycle.

Authors:  Kai Rothkamm; Ines Krüger; Larry H Thompson; Markus Löbrich
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

4.  MDC1 is a mediator of the mammalian DNA damage checkpoint.

Authors:  Grant S Stewart; Bin Wang; Colin R Bignell; A Malcolm R Taylor; Stephen J Elledge
Journal:  Nature       Date:  2003-02-27       Impact factor: 49.962

5.  Nonhomologous end joining and V(D)J recombination require an additional factor.

Authors:  Y Dai; B Kysela; L A Hanakahi; K Manolis; E Riballo; M Stumm; T O Harville; S C West; M A Oettinger; P A Jeggo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

6.  A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome.

Authors:  Mark O'Driscoll; Victor L Ruiz-Perez; C Geoffrey Woods; Penny A Jeggo; Judith A Goodship
Journal:  Nat Genet       Date:  2003-03-17       Impact factor: 38.330

7.  53BP1 promotes ATM activity through direct interactions with the MRN complex.

Authors:  Ji-Hoon Lee; Aaron A Goodarzi; Penny A Jeggo; Tanya T Paull
Journal:  EMBO J       Date:  2009-12-10       Impact factor: 11.598

8.  Role for the BRCA1 C-terminal repeats (BRCT) protein 53BP1 in maintaining genomic stability.

Authors:  Julio C Morales; Zhenfang Xia; Tao Lu; Melissa B Aldrich; Bin Wang; Corina Rosales; Rodney E Kellems; Walter N Hittelman; Stephen J Elledge; Phillip B Carpenter
Journal:  J Biol Chem       Date:  2003-02-10       Impact factor: 5.157

9.  DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1.

Authors:  Oscar Fernandez-Capetillo; Hua-Tang Chen; Arkady Celeste; Irene Ward; Peter J Romanienko; Julio C Morales; Kazuhito Naka; Zhenfang Xia; R Daniel Camerini-Otero; Noboru Motoyama; Phillip B Carpenter; William M Bonner; Junjie Chen; André Nussenzweig
Journal:  Nat Cell Biol       Date:  2002-12       Impact factor: 28.824

10.  Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.

Authors:  Atsushi Hirao; Alison Cheung; Gordon Duncan; Pierre-Marie Girard; Andrew J Elia; Andrew Wakeham; Hitoshi Okada; Talin Sarkissian; Jorge A Wong; Takashi Sakai; Elisa De Stanchina; Robert G Bristow; Toshio Suda; Scott W Lowe; Penny A Jeggo; Stephen J Elledge; Tak W Mak
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

View more
  42 in total

1.  Exo1 plays a major role in DNA end resection in humans and influences double-strand break repair and damage signaling decisions.

Authors:  Nozomi Tomimatsu; Bipasha Mukherjee; Katherine Deland; Akihiro Kurimasa; Emma Bolderson; Kum Kum Khanna; Sandeep Burma
Journal:  DNA Repair (Amst)       Date:  2012-02-11

2.  The Mre11 complex suppresses oncogene-driven breast tumorigenesis and metastasis.

Authors:  Gaorav P Gupta; Katelynd Vanness; Afsar Barlas; Katia O Manova-Todorova; Yong H Wen; John H J Petrini
Journal:  Mol Cell       Date:  2013-10-10       Impact factor: 17.970

3.  A role for homologous recombination proteins in cell cycle regulation.

Authors:  Kaja Kostyrko; Sandra Bosshard; Zuzanna Urban; Nicolas Mermod
Journal:  Cell Cycle       Date:  2015-06-30       Impact factor: 4.534

4.  Src family kinases promote silencing of ATR-Chk1 signaling in termination of DNA damage checkpoint.

Authors:  Yasunori Fukumoto; Mariko Morii; Takahito Miura; Sho Kubota; Kenichi Ishibashi; Takuya Honda; Aya Okamoto; Noritaka Yamaguchi; Atsushi Iwama; Yuji Nakayama; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2014-03-14       Impact factor: 5.157

5.  Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection.

Authors:  Ruth M Densham; Alexander J Garvin; Helen R Stone; Joanna Strachan; Robert A Baldock; Manuel Daza-Martin; Alice Fletcher; Sarah Blair-Reid; James Beesley; Balraj Johal; Laurence H Pearl; Robert Neely; Nicholas H Keep; Felicity Z Watts; Joanna R Morris
Journal:  Nat Struct Mol Biol       Date:  2016-05-30       Impact factor: 15.369

6.  Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins.

Authors:  Rashmi Gupta; Wentian Li; Xiao J Yan; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti Rai; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2019-04-15       Impact factor: 5.422

7.  Identification of a fragment-like small molecule ligand for the methyl-lysine binding protein, 53BP1.

Authors:  Michael T Perfetti; Brandi M Baughman; Bradley M Dickson; Yunxiang Mu; Gaofeng Cui; Pavel Mader; Aiping Dong; Jacqueline L Norris; Scott B Rothbart; Brian D Strahl; Peter J Brown; William P Janzen; Cheryl H Arrowsmith; Georges Mer; Kevin M McBride; Lindsey I James; Stephen V Frye
Journal:  ACS Chem Biol       Date:  2015-01-28       Impact factor: 5.100

8.  The histone variant macroH2A1.1 is recruited to DSBs through a mechanism involving PARP1.

Authors:  Chang Xu; Ye Xu; Ozge Gursoy-Yuzugullu; Brendan D Price
Journal:  FEBS Lett       Date:  2012-09-29       Impact factor: 4.124

9.  Diminished origin-licensing capacity specifically sensitizes tumor cells to replication stress.

Authors:  Kristin M Zimmerman; Rebecca M Jones; Eva Petermann; Penelope A Jeggo
Journal:  Mol Cancer Res       Date:  2013-01-30       Impact factor: 5.852

10.  Ribosomal protein L6 (RPL6) is recruited to DNA damage sites in a poly(ADP-ribose) polymerase-dependent manner and regulates the DNA damage response.

Authors:  Chuanzhen Yang; Weicheng Zang; Yapeng Ji; Tingting Li; Yongfeng Yang; Xiaofeng Zheng
Journal:  J Biol Chem       Date:  2018-12-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.